Clinical Trial Update: A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis [Phase 2]

View source ↗

Summary

A completed Phase II clinical trial evaluating the safety and activity of Dersalazine in adults with mild to moderate Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Dersalazine (dersalazine)

Snippet

Sponsor: Palau Pharma S.L.U. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED